We are live on ! Find out more
RVMDW icon

Revolution Medicines Warrant

22 hedge funds and large institutions have $1.89M invested in Revolution Medicines Warrant in 2023 Q4 according to their latest regulatory filings, with 22 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

4.5% more ownership

Funds ownership: 0% → 4.5% (+4.5%)

Holders
22
Holders Change
+22
Holders Change %
–
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
–
Reduced
–
Closed
–
Calls
$14.5​M
Puts
–
Net Calls
+$14.5​M
Net Calls Change
+$14.5​M

RVMDW Hedge Fund Activity: Q4 2023 in Review

22 of the 6,880 institutional investors tracked by Wall St. Rank reported a position in Revolution Medicines Warrant (RVMDW) for Q4 2023, worth a combined $1.89M.

Buyers outnumbered sellers: 22 funds opened new RVMDW positions and 0 closed out — a net gain of 22 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was D.E. Shaw & Co, opening a new position worth an estimated $602K.

  • 22 institutional investors held Revolution Medicines Warrant (RVMDW) as of Q4 2023, up from 0 in Q3 2023.
  • Funds reported $1.89M of Revolution Medicines Warrant stock for Q4 2023.
  • 22 funds opened new Revolution Medicines Warrant positions in Q4 2023 and 0 closed out, a net change of +22 holders.
  • The largest Revolution Medicines Warrant buyer in Q4 2023 was D.E. Shaw & Co, an estimated $602K added.

Based on aggregated 13F filings for Q4 2023.